share_log

T2 Biosystems | 4: Statement of changes in beneficial ownership of securities-Director Elsbree David B

T2 Biosystems | 4: Statement of changes in beneficial ownership of securities-Director Elsbree David B

T2 Biosystems | 4:持股變動聲明-董事 Elsbree David B
美股SEC公告 ·  09/18 05:05

牛牛AI助理已提取核心訊息

David B Elsbree, associated with T2 Biosystems, Inc. [TTOO], completed a sale of 55 shares of common stock on 09/13/2024. The transaction was executed at a price of $2.42 per share, resulting in a total sale value of $133.1. Following the sale, Elsbree's direct holdings in the company decreased to 23 shares. Additionally, there is an indirect holding of 2 shares through Elsbree's spouse.
David B Elsbree, associated with T2 Biosystems, Inc. [TTOO], completed a sale of 55 shares of common stock on 09/13/2024. The transaction was executed at a price of $2.42 per share, resulting in a total sale value of $133.1. Following the sale, Elsbree's direct holdings in the company decreased to 23 shares. Additionally, there is an indirect holding of 2 shares through Elsbree's spouse.
David b Elsbree,與T2 Biosystems,Inc. [TTOO]相關,於2024年09/13完成了對普通股55股的出售。交易價格爲每股$2.42,總銷售價值爲$133.1。出售後,Elsbree在公司的直接持股減少到23股。另外,通過Elsbree的配偶間接持有2股。
David b Elsbree,與T2 Biosystems,Inc. [TTOO]相關,於2024年09/13完成了對普通股55股的出售。交易價格爲每股$2.42,總銷售價值爲$133.1。出售後,Elsbree在公司的直接持股減少到23股。另外,通過Elsbree的配偶間接持有2股。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。